Century Therapeutics Inc (IPSC) Unusual Options Activity Today

Checking IPSC unusual options activity helps you spot when traders are making outsized bets on Century Therapeutics Inc before the broader market catches on. Century Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor IPSC unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching IPSC unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking IPSC unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and IPSC unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia; and CNTY-106, a CAR-iNK or CAR-iT multi-specific candidate for multiple myeloma.

Century Therapeutics, Inc. was founded in 2018 and is headquartered in Philadelphia, Pennsylvania.

Catalysts rarely arrive without a footprint, and IPSC unusual options activity is often where that footprint shows up first. Our scanner tracks Century Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at IPSC unusual options volume on the call side or chasing put sweeps, Century Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.